Clinical Trials Logo

Morbidity;Newborn clinical trials

View clinical trials related to Morbidity;Newborn.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05116670 Completed - Morality Clinical Trials

Comparison of Care Practices, Mortality and Morbidity of Very Preterm Infants Between Two Tertiary Centers in Northwest and South of China

Start date: October 15, 2021
Phase:
Study type: Observational

Care practices, mortality and morbidity of very premature infants from two different tertiary centers were collected and compared, in order to discover areas for improvement where these two newborn centers can learn from each other.

NCT ID: NCT04103489 Completed - Preeclampsia Severe Clinical Trials

The Use of Eculizumab in HELLP Syndrome

Start date: February 23, 2021
Phase: Phase 1
Study type: Interventional

This research study is being performed to see if women diagnosed with early preterm Hemolysis, Elevated Liver Enzymes, Low Platelets (HELLP) syndrome (estimated gestational ages of 23-30 weeks) benefit from a medication called eculizumab (ECU). This drug blocks a part of the immune system called complement. By blocking this part of the immune system, eculizumab may stop or reverse the progression of the HELLP syndrome disease. The investigators will also look to see if this drug is effective and benefits both the mother and fetus.